Recent News

• 03.20.2025 - Monte Rosa Pipeline Update and Clinical Results Presentation
• 03.20.2025 - Monte Rosa Pipeline Update and Clinical Results Presentation
• 03.20.2025 - Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs
• 03.20.2025 - Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs
• 03.11.2025 - Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
• 03.11.2025 - Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference
• 02.24.2025 - Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
• 02.24.2025 - Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Recent Filings

• 03.20.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.20.2025 - 8-K Current report
• 03.20.2025 - S-3 Registration statement under Securities Act of 1933
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.31.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.30.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors